Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Trifluoroalanine is a fluorinated amino acid derivative that serves as a valuable tool in chemical synthesis and biochemical research. It is utilized as a building block for constructing complex molecules, such as trisubstituted oxazoles and trifluoroalanine dipeptides. In biological systems, Trifluoroalanine functions as an inhibitor for various enzymes, including O-acetylserine sulfhydrylase (OASS), cystathionine β synthase (CBS), cystathionine γ lyase (CSE), 8-amino-7-oxononanoate synthase, tryptophan indole-lyase, tryptophan synthase, alanine racemase, and gamma-cystathionase. Its inhibitory actions often occur through mechanism-based or suicide inactivation, leveraging the unique chemical properties conferred by its trifluoromethyl group. These characteristics make it important for elucidating enzyme mechanisms and exploring potential drug candidates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Trifluoroalanine.